Kevin Balthaser, Chief Financial Officer at Aclaris Therapeutics, Inc. (ACRS), sold 1,894 shares at $12.63 ($24K) on 2023-03-03, disclosed to the SEC on 2023-03-03.
Open-market sale of $24k ACRS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.29 | 1,000 | $12K | 52.1% |
| 2 | $12.63 | 894 | $11K | 47.9% |
| Total | $12.45 avg | 1,894 | $24K | 100% |